Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-5212 in Functional Dyspepsia
NCT05842408Phase 3Completed
- Sponsor
- Dong-A ST
- Start
- Jun 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of DA-5212 in functional dyspepsia (FD), sponsored by Dong-A ST. Started Jun 2023; status: completed.
02
Drugs
DA-5212
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT05842408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05842408.